Correlation Between Medigen Biotechnology and U Media

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and U Media at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and U Media into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Biotechnology and U Media Communications, you can compare the effects of market volatilities on Medigen Biotechnology and U Media and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of U Media. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and U Media.

Diversification Opportunities for Medigen Biotechnology and U Media

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between Medigen and 6470 is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and U Media Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on U Media Communications and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with U Media. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of U Media Communications has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and U Media go up and down completely randomly.

Pair Corralation between Medigen Biotechnology and U Media

Assuming the 90 days trading horizon Medigen Biotechnology is expected to under-perform the U Media. But the stock apears to be less risky and, when comparing its historical volatility, Medigen Biotechnology is 1.41 times less risky than U Media. The stock trades about -0.05 of its potential returns per unit of risk. The U Media Communications is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  5,230  in U Media Communications on September 13, 2024 and sell it today you would earn a total of  60.00  from holding U Media Communications or generate 1.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Medigen Biotechnology  vs.  U Media Communications

 Performance 
       Timeline  
Medigen Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medigen Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Medigen Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
U Media Communications 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in U Media Communications are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, U Media is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Medigen Biotechnology and U Media Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medigen Biotechnology and U Media

The main advantage of trading using opposite Medigen Biotechnology and U Media positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, U Media can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in U Media will offset losses from the drop in U Media's long position.
The idea behind Medigen Biotechnology and U Media Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes